Literature DB >> 24119879

Posterior lumbar interbody fusion for aged patients with degenerative spondylolisthesis: is intentional surgical reduction essential?

Xiao-Feng Lian1, Tie-Sheng Hou, Jian-Guang Xu, Bing-Fang Zeng, Jie Zhao, Xiao-Kang Liu, Cheng Zhao, Hao Li.   

Abstract

BACKGROUND CONTEXT: Surgical reduction and posterior lumbar interbody fusion (PLIF) is commonly used to recover segmental imbalance in degenerative spondylolisthesis. However, whether intentional reduction of the slipped vertebra during PLIF is essential in aged patients with degenerative spondylolisthesis remains controversial.
PURPOSE: We compared the outcomes of surgical reduction and fusion in situ among aged patients who underwent PLIF for degenerative spondylolisthesis. STUDY
DESIGN: A prospective randomized clinical trial on the surgical treatment of degenerative spondylolisthesis patients aged older than 70 years. PATIENT SAMPLE: Between January 2006 and December 2009, 73 patients aged 70 years or older with single-level degenerative spondylolisthesis requiring surgical treatment were included in this study. OUTCOME MEASURES: Clinical outcomes were assessed using the visual analog scale, Oswestry Disability Index, and Japanese Orthopedic Association scores. Radiographic outcomes included percentage of vertebral slippage, focal lordosis, and disc height.
METHODS: The 73 patients were randomly assigned to two groups treated using surgical reduction (Group A, n=36) and fusion in situ (Group B, n=37). Both groups were followed up for an average of 33.2 months (range, 24-54 months). The clinical and radiographic outcomes were compared between the two groups.
RESULTS: Surgical complications were similar in the two groups. The average operative time and blood loss during surgery did not insignificantly differ (p>.05) between the two groups. Spondylolisthesis, disc height, and focal lordosis were significantly improved postoperatively in both groups. There was no obvious difference in clinical outcomes, as assessed using the visual analog scale, Oswestry Disability Index, and Japanese Orthopedic Association scores, although the radiographic outcomes were considerably better in Group A than in Group B.
CONCLUSIONS: Posterior lumbar interbody fusion with pedicle screws fixation, with or without intraoperative reduction, provides good outcomes in the surgical treatment of aged patients with degenerative spondylolisthesis. Better radiological outcomes by intentional reduction do not necessarily indicate better clinical outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aged patients; Degenerative spondylolisthesis; Pedicle screws; Posterior lumbar interbody fusion; Surgical reduction

Mesh:

Year:  2013        PMID: 24119879     DOI: 10.1016/j.spinee.2013.07.481

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  13 in total

1.  Posterior Arch Augmentation (Spinoplasty) before and after Single and Double Interspinous Spacer Introduction at the Same Level: Preventing and Treating the Failure?

Authors:  Luigi Manfré
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

Review 2.  Surgery for adult spondylolisthesis: a systematic review of the evidence.

Authors:  Tobias L Schulte; Florian Ringel; Markus Quante; Sven O Eicker; Cathleen Muche-Borowski; Ralph Kothe
Journal:  Eur Spine J       Date:  2015-09-12       Impact factor: 3.134

Review 3.  Is reduction better than arthrodesis in situ in surgical management of low-grade spondylolisthesis? A system review and meta analysis.

Authors:  Xuedong Bai; Jiahai Chen; Liyang Liu; Xiaochuan Li; Yaohong Wu; Deli Wang; Dike Ruan
Journal:  Eur Spine J       Date:  2016-11-10       Impact factor: 3.134

4.  Lumbar spinal fusion of low-grade degenerative spondylolisthesis (Meyerding grade I and II): Do reduction and correction of the radiological sagittal parameters correlate with better clinical outcome?

Authors:  Stavros Oikonomidis; Carolin Meyer; Max Joseph Scheyerer; David Grevenstein; Peer Eysel; Jan Bredow
Journal:  Arch Orthop Trauma Surg       Date:  2019-11-16       Impact factor: 3.067

5.  Does change in focal lordosis after spinal fusion affect clinical outcomes in degenerative spondylolisthesis?

Authors:  Brian A Karamian; Stephen DiMaria; Mark J Lambrechts; Nicholas D D'Antonio; Andrew Sawires; Jose A Canseco; I David Kaye; Barrett I Woods; Mark F Kurd; Jeffery A Rihn; Joseph K Lee; Alan S Hilibrand; Christopher K Kepler; Alexander R Vaccaro; Gregory D Schroeder
Journal:  J Craniovertebr Junction Spine       Date:  2022-06-13

6.  Does Transforaminal Lumbar Interbody Fusion Have Advantages over Posterolateral Lumbar Fusion for Degenerative Spondylolisthesis?

Authors:  Takahito Fujimori; Hai Le; William W Schairer; Sigurd H Berven; Erion Qamirani; Serena S Hu
Journal:  Global Spine J       Date:  2014-12-01

7.  Lever reduction using polyaxial screw and rod fixation system for the treatment of degenerative lumbar spondylolisthesis with spinal stenosis: technique and clinical outcome.

Authors:  Zu-De Liu; Xin-Feng Li; Lie Qian; Lian-Ming Wu; Li-Feng Lao; Han-Tao Wang
Journal:  J Orthop Surg Res       Date:  2015-02-15       Impact factor: 2.359

Review 8.  A comparison of posterior lumbar interbody fusion and transforaminal lumbar interbody fusion: a literature review and meta-analysis.

Authors:  Qunhu Zhang; Zhen Yuan; Min Zhou; Huan Liu; Yong Xu; Yongxin Ren
Journal:  BMC Musculoskelet Disord       Date:  2014-11-05       Impact factor: 2.362

9.  Clinical Outcomes of Posterior Lumbar Interbody Fusion for Patients 80 Years of Age and Older with Lumbar Degenerative Disease: Minimum 2 Years' Follow-Up.

Authors:  Kazunori Hayashi; Akira Matsumura; Sadahiko Konishi; Minori Kato; Takashi Namikawa; Hiroaki Nakamura
Journal:  Global Spine J       Date:  2016-02-19

10.  A new lever reduction technique for the surgical treatment of elderly patients with lumbar degenerative Spondylolisthesis.

Authors:  Chao Kong; Wei Wang; Xiangyu Li; Xiangyao Sun; Junzhe Ding; Shibao Lu
Journal:  BMC Musculoskelet Disord       Date:  2020-01-07       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.